Immune signatures predictive of optimal cytoreduction in ovarian cancer

被引：0
|
作者：
Simons, E. [1 ]
Kiet, T. [1 ]
Amanam, I. [1 ]
Ho, M. [1 ]
Fuh, J. [1 ]
Fuh, K. [1 ]
Kapp, D. [2 ]
Odunsi, K. [3 ]
Chan, J. [1 ]
机构：
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
107
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [1] SPLENECTOMY FOR OPTIMAL CYTOREDUCTION IN OVARIAN-CANCER
    MALFETANO, JH
    GYNECOLOGIC ONCOLOGY, 1986, 24 (03) : 392 - 394
  • [2] Optimal cytoreduction for advanced epithelial ovarian cancer: A commentary
    Eisenkop, Scott M.
    Spirtos, Nick M.
    Lin, Wei-Chien Michael
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 329 - 335
  • [3] Predictive value of preoperative abdominopelvic CT for optimal cytoreduction surgery in ovarian carcinoma
    Taieb, S
    Bonodeau, F
    Leblanc, E
    Vennin, P
    Fournier, C
    Besson, P
    BULLETIN DU CANCER, 2000, 87 (03) : 265 - 272
  • [4] Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma
    Fagotti, Anna
    Ferrandina, Gabriella
    Fanfani, Francesco
    Garganese, Giorgia
    Vizzielli, Giuseppe
    Carone, Vito
    Salerno, Maria Giovanna
    Scambia, Giovanni
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : 642.e1 - 642.e6
  • [5] The use of molecular markers to predict for optimal cytoreduction in ovarian cancer
    Fuh, K.
    Kiet, T. K.
    Chen, L.
    Brooks, R. A.
    Sherman, A. E.
    Kapp, D. S.
    Chan, J. K.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 436 - 437
  • [6] PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER
    Fagotti, A.
    Vizzielli, G.
    Tortorella, L.
    Fanfani, F.
    Costantini, B.
    Ferrandina, G.
    Gallotta, V.
    Alletti, S. Gueli
    Iodice, R.
    Scambia, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [7] The use of molecular markers to predict for optimal cytoreduction in ovarian cancer
    Fuh, K.
    Kiet, T.
    Chen, L.
    Sherman, A.
    Kapp, D.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S13 - S13
  • [8] Development of a predictive signatures for immune therapy in ovarian cancer: Whom to treat and whom not to treat?
    Talukdar, S.
    Cepela, J.
    Chang, Z.
    Zhang, Y.
    Mullany, S. A.
    Nelson, A. C.
    Starr, T.
    Winterhoff, B.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 36 - 36
  • [9] Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer
    Hidayat, Yudi Mulyana
    Munizar
    Harsono, Ali Budi
    Winarno, Gatot Nyarumenteng Adhipurnawan
    Hasanuddin
    Salima, Siti
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2020, 13 : 1201 - 1206
  • [10] Cytoreduction for ovarian cancer
    Day, F.
    Braslington, N.
    Morrison, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 32 - 33
12345